Market revenue in 2023 | USD 5.0 million |
Market revenue in 2030 | USD 8.9 million |
Growth rate | 8.8% (CAGR from 2023 to 2030) |
Largest segment | Human donor tissue-derived products |
Fastest growing segment | Human Donor Tissue-Derived Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human Donor Tissue-Derived Products, Acellular Animal-derived Products |
Key market players worldwide | 3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological skin substitutes market will help companies and investors design strategic landscapes.
Human donor tissue-derived products was the largest segment with a revenue share of 66% in 2023. Horizon Databook has segmented the Sweden biological skin substitutes market based on human donor tissue-derived products, acellular animal-derived products covering the revenue growth of each sub-segment from 2018 to 2030.
According to Business Monitor International, Sweden is the fourth most attractive market in Western Europe for the commercialization of medical devices. Domestic production is strong in areas such as hospital wheelchairs, sterilizers, and blood pressure monitors.
The majority of the local production is for export. The medical device manufacturing industry in Sweden is relatively small and employs approximately 18,000 people. The majority of manufacturing firms are small to mid-size companies with a small number of MNCs having their own local subsidiaries.
The International Trade Administration states that Sweden’s healthcare system is one of the most well-developed healthcare systems in the world. The average life expectancy in the country is 84 years for women and 81 years for men. The country has one of the oldest geriatric population in the world, which is 19.8%.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden biological skin substitutes market , including forecasts for subscribers. This country databook contains high-level insights into Sweden biological skin substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account